{"References": [{"title": "Clonal heterogeneity and tumor evolution: past, present, and the future", "authors": "Charles Swanton", "journal": "Cell", "year": "2012", "volumes": "148", "first page": "33", "last page": "45", "DOI": "10.1016/j.cell.2011.12.023"}, {"title": "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing", "authors": "Marco Gerlinger, Andrew J. Rowan, Stuart Horswell, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart, Patrick Tarpey", "journal": "New England Journal of Medicine", "year": "2012", "volumes": "366", "first page": "883", "last page": "892", "DOI": "10.1056/NEJMoa1113205"}, {"title": "The role of intratumoral heterogeneity in cancer immunotherapy", "authors": "Nicholas McGranahan, Charles Swanton", "journal": "Clinical Cancer Research", "year": "2017", "volumes": "23", "first page": "2619", "last page": "2629", "DOI": "10.1158/1078-0432.CCR-16-1422"}, {"title": "Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion", "authors": "Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth", "journal": "Science", "year": "2011", "volumes": "331", "first page": "1565", "last page": "1570", "DOI": "10.1126/science.1203486"}, {"title": "Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade", "authors": "Nicholas McGranahan, Andrew J. Furness, Rachel Rosenthal, Sachet A. Shukla, Cristina Y. Menzies, Ludmil B. Alexandrov, David J. Adams, Katherine S. Harris, Samuel A. Fisher", "journal": "Science", "year": "2016", "volumes": "351", "first page": "1463", "last page": "1469", "DOI": "10.1126/science.aaf1490"}, {"title": "The impact of tumor heterogeneity on immune checkpoint blockade", "authors": "Taha Merghoub, Jedd D. Wolchok", "journal": "Cancer Immunology Research", "year": "2016", "volumes": "4", "first page": "1", "last page": "8", "DOI": "10.1158/2326-6066.CIR-15-0283"}, {"title": "Intratumor heterogeneity: the Rosetta Stone of therapy resistance", "authors": "Alberto Bardelli, Alberto Sottoriva", "journal": "Cancer Cell", "year": "2017", "volumes": "31", "first page": "1", "last page": "3", "DOI": "10.1016/j.ccell.2016.12.007"}, {"title": "Tumor heterogeneity and resistance to cancer therapies", "authors": "Kenneth P. Olive, David A. Tuveson", "journal": "Nature Reviews Clinical Oncology", "year": "2018", "volumes": "15", "first page": "81", "last page": "94", "DOI": "10.1038/nrclinonc.2017.166"}, {"title": "The immune contexture in human tumours: impact on clinical outcome", "authors": "Jérôme Galon, Franck Pagès, Francesco M. Marincola, Helen K. Angell, Magdalena Thurin, Alessandro Lugli, Inti Zlobec, Anne Berger, Carlo Bifulco, Bernard A. Fox", "journal": "Nature Reviews Cancer", "year": "2012", "volumes": "12", "first page": "298", "last page": "306", "DOI": "10.1038/nrc3245"}, {"title": "Immune checkpoint blockade: a common denominator approach to cancer therapy", "authors": "James P. Allison, Antoni Ribas", "journal": "Cancer Cell", "year": "2015", "volumes": "27", "first page": "450", "last page": "461", "DOI": "10.1016/j.ccell.2015.03.001"}]}